TOKYO–(Healthcare Sales & Marketing Network)–Sorin Group, (Reuters Code: SORN.MI), a global medical device company and a leader in the treatment of cardiovascular diseases, announces that it received authorization from the Japanese Pharmaceuticals and Me… Devices, Cardiology, Regulatory Sorin Group, MEMO 3D, Annuloplasty Ring

See more here:
Sorin Group Receives Regulatory Approval to Market Memo 3D(TM) Annuloplasty Ring in Japan

SINGAPORE, March 9, 2012 /PRNewswire-Asia/ — Biosensors International Group, Ltd. (“Biosensors” or the “Group”, Bloomberg: BIG SP; Reuters: BIOS.SI; SGX: B20), a developer, manufacturer and marketer of innovative medical devices, today… Devices, Interventional Cardiology, Personnel Biosensors International Group, Biosensors, drug eluting stent

Link:
Biosensors Makes Organizational Changes to Senior Management Team to Prepare for Continued Growth

CHELMSFORD, Mass.–(BUSINESS WIRE)–ZOLL Medical Corporation (NASDAQ:ZOLL), a manufacturer of medical devices and related software solutions, today announced it will report its first quarter results following the close of the market on January 19, 2012. The Company will hold a conference call on that date at 5:00 p.m. Eastern Time (EST) to discuss its quarterly results, business highlights and outlook. This call will be webcast by Thomson Reuters and can be accessed at ZOLL’s web site at www.zol

Original post:
ZOLL Medical Corporation First Quarter Conference Call Notification

SINGAPORE, Dec. 30, 2011 /PRNewswire-Asia/ — Biosensors International Group, Ltd. (“Biosensors” or the “Company”, Bloomberg: BIG:SP; Reuters: BIOS.SI; SGX: B20), a developer, manufacturer and marketer of innovative medical devices for interventional cardiology and critical care…

View original post here:
Biosensors International to Participate in the 30th Annual J.P. Morgan Healthcare Conference

LIMERICK, Pa.–(BUSINESS WIRE)–Teleflex Incorporated (NYSE: TFX), a leading global provider of medical devices for critical care and surgery, has issued a statement in response to an incorrect notice posted on the Thompson Reuters website. The Thomson Reuters report on its website yesterday mistakenly reported that Dr. Ming S. Liu was named CEO of Teleflex Incorporated. This statement was incorrect and solely the result of Thomson Reuters error in not using the correct stock ticker symbol for P

See the article here:
Teleflex Incorporated Issues Statement: No Changes to Teleflex Incorporated Leadership